- Home
- BDTX vs FRGE Comparison
BDTX vs FRGE Comparison
Compare BDTX & FRGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDTX
- FRGE
- Stock Information
- Founded
- BDTX 2014
- FRGE 2014
- Country
- BDTX United States
- FRGE United States
- Employees
- BDTX N/A
- FRGE N/A
- Industry
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- FRGE Computer Software: Prepackaged Software
- Sector
- BDTX Health Care
- FRGE Technology
- Exchange
- BDTX Nasdaq
- FRGE Nasdaq
- Market Cap
- BDTX 132.5M
- FRGE 175.1M
- IPO Year
- BDTX 2020
- FRGE N/A
- Fundamental
- Price
- BDTX $2.58
- FRGE $18.28
- Analyst Decision
- BDTX Strong Buy
- FRGE Buy
- Analyst Count
- BDTX 6
- FRGE 5
- Target Price
- BDTX $14.83
- FRGE $38.25
- AVG Volume (30 Days)
- BDTX 1.3M
- FRGE 115.5K
- Earning Date
- BDTX 08-05-2025
- FRGE 08-06-2025
- Dividend Yield
- BDTX N/A
- FRGE N/A
- EPS Growth
- BDTX N/A
- FRGE N/A
- EPS
- BDTX 0.09
- FRGE N/A
- Revenue
- BDTX $70,000,000.00
- FRGE $85,383,000.00
- Revenue This Year
- BDTX N/A
- FRGE $18.22
- Revenue Next Year
- BDTX N/A
- FRGE $29.35
- P/E Ratio
- BDTX $29.29
- FRGE N/A
- Revenue Growth
- BDTX N/A
- FRGE 16.04
- 52 Week Low
- BDTX $1.20
- FRGE $6.60
- 52 Week High
- BDTX $6.75
- FRGE $24.45
- Technical
- Relative Strength Index (RSI)
- BDTX 60.64
- FRGE 68.75
- Support Level
- BDTX $2.43
- FRGE $18.15
- Resistance Level
- BDTX $2.72
- FRGE $19.94
- Average True Range (ATR)
- BDTX 0.18
- FRGE 1.02
- MACD
- BDTX -0.00
- FRGE 0.06
- Stochastic Oscillator
- BDTX 76.11
- FRGE 75.20
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.
About FRGE Forge Global Holdings Inc.
Forge Global Holdings Inc is a financial service platform created to serve the needs of the private market. It provides marketplace infrastructure, data services, and technology solutions for private market participants. The company offers a trusted trading platform, proprietary data and insights to inform investment strategies, along with custody services to help companies, shareholders, institutions and accredited investors confidently navigate and transact in the private market.